Sigilon Therapeutics Augments Intellectual Property Portfolio with Recent U.S. Patents Business Wire
Sigilon Therapeutics today announced the addition to its patent portfolio of U.S. Patent Nos. 10285949 and 10292936.
Sigilon Therapeutics Augments Intellectual Property Portfolio with Recent U.S. Patents Business Wire
Sigilon Therapeutics today announced the addition to its patent portfolio of U.S. Patent Nos. 10285949 and 10292936.